Medication in ASD — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Start risperidone (low-dose, off-label) with careful monitoring
Risperidone (low-dose) is approved in Australia for behavioural disturbance in autism when behavioural strategies have failed. It reduces irritability, aggression, and self-injury. Monitoring for metabolic side effects (weight gain, dyslipidaemia, hyperglycaemia), prolactin elevation, and extrapyramidal effects is essential.
Reference: RACP – 2024 – Paediatric Curriculum: ASD Management